RankAlpha logo
Back to Rankings

RXRX

RecursionF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
RXRX vs peer average
30/100
RXRX vs. peer average (F vs. D)
Grade spread
B 2 · D 4 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

TRVI is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $1.92B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerTRVITrevi Therapeutics
RXRX
Recursion
TRVI
Trevi Therapeutics
Grade
F
D
Momentum
14
82
Value
41
41
Sentiment
-
0
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs TRVI

RXRX / TRVI
Grade Position
Below peers
RXRX vs. peer average (F vs. D)
30/100
Momentum
14
TRVI
Value
41
RXRX
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RXRX
1
TRVI
Trevi Therapeutics Inc Common
D
40/100
-1
2
MESO
Mesoblast Ltd ADR
F
20/100
Even
3
BHC
Bausch Health Companies Inc Common
D
40/100
-1
4
ABCL
AbCellera Biologics Inc Common
B
80/100
-3
5
ZLAB
Zai Lab Ltd ADR
F
20/100
Even
TRVI is the first peer returned for this comparison set.